Literature DB >> 6285406

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.

A W Zuardi, I Shirakawa, E Finkelfarb, I G Karniol.   

Abstract

The object of the experiment was to verify whether cannabidiol (CBD) reduces the anxiety provoked by delta 9-THC in normal volunteers, and whether this effect occurs by a general block of the action of delta 9-THC or by a specific anxiolytic effect. Appropriate measurements and scales were utilized and the eight volunteers received, the following treatments in a double-blind procedure: 0.5 mg/kg delta 9-THC, 1 mg/kg CBD, a mixture containing 0.5 mg/kg delta 9-THC and 1 mg/kg CBD and placebo and diazepam (10 mg) as controls. Each volunteer received the treatments in a different sequence. It was verified that CBD blocks the anxiety provoked by delta 9-THC, however this effect also extended to marihuana-like effects and to other subjective alterations induced by delta 9-THC. This antagonism does not appear to be caused by a general block of delta 9-THC effects, since no change was detected in the pulse-rate measurements. Several further effects were observed typical of CBD and of an opposite nature to those of delta 9-THC. These results suggest that the effects of CBD, as opposed to those of delta 9-THC, might be involved in the antagonism of effects between the two cannabinoids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285406     DOI: 10.1007/bf00432554

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Intravenous delta9-Tetrahydrocannabinol: Effects of ventilatory control and cardiovascular dynamics.

Authors:  L A Malit; R E Johnstone; D I Bourke; R A Kulp; V Klein; T C Smith
Journal:  Anesthesiology       Date:  1975-06       Impact factor: 7.892

2.  The effect on personality of reactivity to 1,2-dimethyl-heptyl tetrahydrocannabinol.

Authors:  J A Klapper; M A McColloch; F R Sidell
Journal:  Arch Gen Psychiatry       Date:  1972-05

3.  Effects of cannabidiol and delta-9-tetrahydrocannabinol on operant behavior.

Authors:  W M Davis; L A Borgen
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-11

4.  Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.

Authors:  M Fernandes; A Schabarek; H Coper; R Hill
Journal:  Psychopharmacologia       Date:  1974

5.  Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol.

Authors:  I G Karniol; E A Carlini
Journal:  Pharmacology       Date:  1973       Impact factor: 2.547

Review 6.  Marihuana in man: three years later.

Authors:  L E Hollister
Journal:  Science       Date:  1971-04-02       Impact factor: 47.728

7.  A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol.

Authors:  M Perez-Reyes; M C Timmons; K H Davis; E M Wall
Journal:  Experientia       Date:  1973-11-15

8.  The action of sedatives on brain stem oculomotor systems in man.

Authors:  H Norris
Journal:  Neuropharmacology       Date:  1971-03       Impact factor: 5.250

9.  Dose-response analysis of the effects of tetrahydrocannabinol in man.

Authors:  G F Kiplinger; J E Manno; B E Rodda; R B Forney
Journal:  Clin Pharmacol Ther       Date:  1971 Jul-Aug       Impact factor: 6.875

Review 10.  Cannabis: a psychopharmacological review.

Authors:  P Bech; L Rafaelsen; O J Rafaelsen
Journal:  Dan Med Bull       Date:  1974-05
View more
  149 in total

1.  Cannabis is more than simply delta(9)-tetrahydrocannabinol.

Authors:  Ethan B Russo; John M McPartland
Journal:  Psychopharmacology (Berl)       Date:  2002-12-19       Impact factor: 4.530

2.  Cannabis--a valuable drug that deserves better treatment.

Authors:  Raphael Mechoulam
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment.

Authors:  L Cinnamon Bidwell; Jarrod M Ellingson; Hollis C Karoly; Sophie L YorkWilliams; Leah N Hitchcock; Brian L Tracy; Jost Klawitter; Cristina Sempio; Angela D Bryan; Kent E Hutchison
Journal:  JAMA Psychiatry       Date:  2020-08-01       Impact factor: 21.596

4.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

5.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

Review 6.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 7.  What is the mechanism whereby cannabis use increases risk of psychosis?

Authors:  Sonija Luzi; Paul D Morrison; John Powell; Marta di Forti; Robin M Murray
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 8.  The endocannabinoid system as a target for novel anxiolytic drugs.

Authors:  Sachin Patel; Mathew N Hill; Joseph F Cheer; Carsten T Wotjak; Andrew Holmes
Journal:  Neurosci Biobehav Rev       Date:  2017-05       Impact factor: 8.989

9.  Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.

Authors:  T V Zanelati; C Biojone; F A Moreira; F S Guimarães; Sâmia R L Joca
Journal:  Br J Pharmacol       Date:  2009-12-04       Impact factor: 8.739

10.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.